{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:17:15Z","timestamp":1790864235431,"version":"4.1.0"},"reference-count":239,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Osteoarthritis, rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, all have one clear common denominator; an altered turnover of bone. However, this may be more complex than a simple change in bone matrix and mineral turnover. While these diseases share a common tissue axis, their manifestations in the area of pathology are highly diverse, ranging from sclerosis to erosion of bone in different regions. The management of these diseases will benefit from a deeper understanding of the local versus systemic effects, the relation to the equilibrium of the bone balance (i.e., bone formation versus bone resorption), and the physiological and pathophysiological phenotypes of the cells involved (e.g., osteoblasts, osteoclasts, osteocytes and chondrocytes). For example, the process of endochondral bone formation in chondrocytes occurs exists during skeletal development and healthy conditions, but also in pathological conditions. This review focuses on the complex molecular and cellular taxonomy of bone in the context of rheumatological diseases that alter bone matrix composition and maintenance, giving rise to different bone turnover phenotypes, and how biomarkers (biochemical markers) can be applied to potentially describe specific bone phenotypic tissue profiles.<\/jats:p>","DOI":"10.1186\/s12891-020-03804-2","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T16:02:34Z","timestamp":1606579354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Bone phenotypes in rheumatology \u2013 there is more to bone than just bone"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-1417","authenticated-orcid":false,"given":"Christian S.","family":"Thudium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Holm","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samra","family":"Sardar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mobasheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem Evert","family":"van Spil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Lories","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Christine","family":"Bay-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,28]]},"reference":[{"key":"3804_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.berh.2014.10.008","volume":"28","author":"RJ Lories","year":"2014","unstructured":"Lories RJ, Haroon N. Bone formation in axial spondyloarthritis. Best Pract Res Clin Rheumatol. 2014;28:765\u201377. https:\/\/doi.org\/10.1016\/j.berh.2014.10.008.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3804_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1210\/er.2010-0006","volume":"32","author":"K Henriksen","year":"2011","unstructured":"Henriksen K, Bollerslev J, Everts V, Karsdal MA. Osteoclast activity and subtypes as a function of physiology and pathology - implications for future treatments of osteoporosis. Endocr Rev. 2011;32:31\u201363. https:\/\/doi.org\/10.1210\/er.2010-0006.","journal-title":"Endocr Rev"},{"key":"3804_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.berh.2014.01.004","volume":"28","author":"VL Johnson","year":"2014","unstructured":"Johnson VL, Hunter DJ. The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol. 2014;28:5\u201315. https:\/\/doi.org\/10.1016\/j.berh.2014.01.004.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3804_CR4","doi-asserted-by":"publisher","first-page":"ii56","DOI":"10.1093\/rheumatology\/kew345","volume":"55","author":"SR Goldring","year":"2016","unstructured":"Goldring SR. Differential mechanisms of de-regulated bone formation in rheumatoid arthritis and spondyloarthritis. Rheumatology (Oxford). 2016;55:ii56\u201360. https:\/\/doi.org\/10.1093\/rheumatology\/kew345.","journal-title":"Rheumatology (Oxford)"},{"key":"3804_CR5","doi-asserted-by":"publisher","unstructured":"Goldring SR, Goldring MB. Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage\u2013bone crosstalk. Rheumatol: Nat Rev. 2016. https:\/\/doi.org\/10.1038\/nrrheum.2016.148.","DOI":"10.1038\/nrrheum.2016.148"},{"key":"3804_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrrheum.2012.153.Bone","volume":"8","author":"G Schett","year":"2012","unstructured":"Schett G, Gravallese EM. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol. 2012;8:656\u201364. https:\/\/doi.org\/10.1038\/nrrheum.2012.153.Bone.","journal-title":"Nat Rev Rheumatol"},{"key":"3804_CR7","first-page":"24","volume":"128","author":"EM Gravallese","year":"2017","unstructured":"Gravallese EM. Bone Wasn\u2019t built in a Day: destruction and formation of Bone in the rheumatic diseases. Trans Am Clin Climatol Assoc. 2017;128:24\u201343 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28790485.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"3804_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","volume":"13","author":"G Schett","year":"2017","unstructured":"Schett G, Lories RJ, D\u2019Agostino M-A, Elewaut D, Kirkham B, Soriano ER, et al. Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol. 2017;13:731\u201341. https:\/\/doi.org\/10.1038\/nrrheum.2017.188.","journal-title":"Nat Rev Rheumatol"},{"key":"3804_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/annrheumdis-2013-204111","volume":"73","author":"MA Karsdal","year":"2014","unstructured":"Karsdal MA, Bay-Jensen AC, Lories RJ, Abramson S, Spector T, Pastoureau P, et al. The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments? Ann Rheum Dis. 2014;73:336\u201348. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204111.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bone.2011.10.010","volume":"51","author":"S Suri","year":"2012","unstructured":"Suri S, Walsh DA. Osteochondral alterations in osteoarthritis. Bone. 2012;51:204\u201311. https:\/\/doi.org\/10.1016\/j.bone.2011.10.010.","journal-title":"Bone"},{"key":"3804_CR11","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.joca.2008.01.014","volume":"16","author":"MA Karsdal","year":"2008","unstructured":"Karsdal MA, Leeming DJ, Dam EB, Henriksen K, Alexandersen P, Pastoureau P, et al. Should subchondral bone turnover be targeted when treating osteoarthritis? Osteoarthr Cartil. 2008;16:638\u201346. https:\/\/doi.org\/10.1016\/j.joca.2008.01.014.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR12","doi-asserted-by":"publisher","first-page":"48745","DOI":"10.1074\/jbc.M309193200","volume":"278","author":"K Henriksen","year":"2003","unstructured":"Henriksen K, Karsdal M, Delaiss\u00e9 JM, Engsig MT. RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1\/2-dependent mechanism. J Biol Chem. 2003;278:48745\u201353. https:\/\/doi.org\/10.1074\/jbc.M309193200.","journal-title":"J Biol Chem"},{"key":"3804_CR13","first-page":"1","volume-title":"Prim. Metab. Bone dis. Disord. Miner. Metab","author":"R Baron","year":"2003","unstructured":"Baron R. Anatomy and biology of bone matrix and cellular elements. In: Prim. Metab. Bone dis. Disord. Miner. Metab. Washington: American Society for Bone and Mineral Research; 2003. p. 1\u20138."},{"key":"3804_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3109\/03008209609029201","volume":"35","author":"DC Hermey","year":"1996","unstructured":"Hermey DC, Popoff SN, Marks SC. Reduced bone resorption in toothless (osteopetrotic) rats--an abnormality of osteoblasts related to their inability to activate osteoclast activity in vitro. Connect Tissue Res. 1996;35:273\u20138 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9084666.","journal-title":"Connect Tissue Res"},{"key":"3804_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1530\/JOE-11-0048","volume":"211","author":"EJ Mackie","year":"2011","unstructured":"Mackie EJ, Tatarczuch L, Mirams M. The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification. J Endocrinol. 2011;211:109\u201321. https:\/\/doi.org\/10.1530\/JOE-11-0048.","journal-title":"J Endocrinol"},{"key":"3804_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bone.2015.04.035","volume":"80","author":"AD Berendsen","year":"2015","unstructured":"Berendsen AD, Olsen BR. Bone development. Bone. 2015;80:14\u20138. https:\/\/doi.org\/10.1016\/j.bone.2015.04.035.","journal-title":"Bone."},{"key":"3804_CR17","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1056\/NEJMra053077","volume":"354","author":"E Seeman","year":"2006","unstructured":"Seeman E, Delmas PD. Bone quality--the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354:2250\u201361. https:\/\/doi.org\/10.1056\/NEJMra053077.","journal-title":"N Engl J Med"},{"key":"3804_CR18","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.bone.2009.03.671","volume":"44","author":"K Henriksen","year":"2009","unstructured":"Henriksen K, Neutzsky-Wulff AV, Bonewald LF, Karsdal MA. Local communication on and within bone controls bone remodeling. Bone. 2009;44:1026\u201333. https:\/\/doi.org\/10.1016\/j.bone.2009.03.671.","journal-title":"Bone"},{"key":"3804_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1359\/jbmr.070109","volume":"22","author":"MA Karsdal","year":"2007","unstructured":"Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K. Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res. 2007;22:487\u201394. https:\/\/doi.org\/10.1359\/jbmr.070109.","journal-title":"J Bone Miner Res"},{"key":"3804_CR20","first-page":"437","volume":"15","author":"H Takahashi","year":"1964","unstructured":"Takahashi H, Epker B, Frost HM. Resorption precedes formative activity. Surg Forum. 1964;15:437\u20138.","journal-title":"Surg Forum"},{"key":"3804_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/206489a0","volume":"206","author":"R Hattner","year":"1965","unstructured":"Hattner R, Epker BN, Frost HM. Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature. 1965;206:489\u201390. https:\/\/doi.org\/10.1038\/206489a0.","journal-title":"Nature."},{"key":"3804_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0221-8747(82)90002-9","volume":"4","author":"AM Parfitt","year":"1982","unstructured":"Parfitt AM. The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. Metab Bone Dis Relat Res. 1982;4:1\u20136 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7121250.","journal-title":"Metab Bone Dis Relat Res"},{"key":"3804_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2015.10.013","volume":"49","author":"AT Shaw","year":"2016","unstructured":"Shaw AT, Gravallese EM. Mediators of inflammation and bone remodeling in rheumatic disease. Semin Cell Dev Biol. 2016;49:2\u201310. https:\/\/doi.org\/10.1016\/j.semcdb.2015.10.013.","journal-title":"Semin Cell Dev Biol"},{"key":"3804_CR24","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","volume":"377","author":"TD Rachner","year":"2011","unstructured":"Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet (London, England). 2011;377:1276\u201387. https:\/\/doi.org\/10.1016\/S0140-6736(10)62349-5.","journal-title":"Lancet (London, England)"},{"key":"3804_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1042\/CS20060046","volume":"112","author":"TJ Martin","year":"2007","unstructured":"Martin TJ, Seeman E. New mechanisms and targets in the treatment of bone fragility. Clin Sci (Lond). 2007;112:77\u201391. https:\/\/doi.org\/10.1042\/CS20060046.","journal-title":"Clin Sci (Lond)"},{"key":"3804_CR26","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1056\/NEJMra053077","volume":"354","author":"E Seeman","year":"2006","unstructured":"Seeman E, Delmas PD. Bone quality--the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354:2250\u201361. https:\/\/doi.org\/10.1056\/NEJMra053077.","journal-title":"N Engl J Med"},{"key":"3804_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00198-006-0286-8","volume":"18","author":"K Henriksen","year":"2007","unstructured":"Henriksen K, Tanko LB, Qvist P, Delmas PD, Christiansen C, Karsdal MA. Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases. Osteoporos Int. 2007;18:681\u20135. https:\/\/doi.org\/10.1007\/s00198-006-0286-8.","journal-title":"Osteoporos Int"},{"key":"3804_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jbmr.173","volume":"26","author":"D Padhi","year":"2011","unstructured":"Padhi D, Jang G, Stouch B, Fang L, Posvar E. Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res. 2011;26:19\u201326. https:\/\/doi.org\/10.1002\/jbmr.173.","journal-title":"J Bone Miner Res"},{"key":"3804_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-11-201","volume":"11","author":"G Wheater","year":"2013","unstructured":"Wheater G, Elshahaly M, Tuck SP, Datta HK, van Laar JM. The clinical utility of bone marker measurements in osteoporosis. J Transl Med. 2013;11:1. https:\/\/doi.org\/10.1186\/1479-5876-11-201.","journal-title":"J Transl Med"},{"key":"3804_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-020-3170-3","volume":"21","author":"D She","year":"2020","unstructured":"She D, Li R, Fang P, Zong G, Xue Y, Zhang K. Serum osteocalcin level is associated with the mortality in Chinese patients with Fibrodysplasia ossificans progressiva aged \u226418 years at diagnosis. BMC Musculoskelet Disord. 2020;21:1\u20138. https:\/\/doi.org\/10.1186\/s12891-020-3170-3.","journal-title":"BMC Musculoskelet Disord"},{"key":"3804_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1530\/eje.0.1330557","volume":"133","author":"J Bollerslev","year":"1995","unstructured":"Bollerslev J, Thomas S, Grodum E, Brixen K, Dj\u00f8seland O. Collagen metabolism in two types of autosomal dominant osteopetrosis during stimulation with thyroid hormones. Eur J Endocrinol. 1995;133:557\u201363. https:\/\/doi.org\/10.1530\/eje.0.1330557.","journal-title":"Eur J Endocrinol"},{"key":"3804_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00223-014-9865-4","volume":"95","author":"CS Thudium","year":"2014","unstructured":"Thudium CS, Moscatelli I, Flores C, Thomsen JS, Br\u00fcel A, Gudmann NS, et al. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation. Calcif Tissue Int. 2014;95:83\u201393. https:\/\/doi.org\/10.1007\/s00223-014-9865-4.","journal-title":"Calcif Tissue Int"},{"key":"3804_CR33","doi-asserted-by":"publisher","first-page":"e27482","DOI":"10.1371\/journal.pone.0027482","volume":"6","author":"K Henriksen","year":"2011","unstructured":"Henriksen K, Flores C, Thomsen JS, Br\u00fcel A-M, Thudium CS, Neutzsky-Wulff AV, et al. Dissociation of bone resorption and bone formation in adult mice with a non-functional V-ATPase in osteoclasts leads to increased bone strength. PLoS One. 2011;6:e27482. https:\/\/doi.org\/10.1371\/journal.pone.0027482.","journal-title":"PLoS One"},{"key":"3804_CR34","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1373\/clinchem.2003.029355","volume":"50","author":"SL Alatalo","year":"2004","unstructured":"Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, V\u00e4\u00e4n\u00e4nen HK, Halleen JM. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis). Clin Chem. 2004;50:883\u201390. https:\/\/doi.org\/10.1373\/clinchem.2003.029355.","journal-title":"Clin Chem"},{"key":"3804_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00223-001-2122-7","volume":"71","author":"JM Halleen","year":"2002","unstructured":"Halleen JM, Ylipahkala H, Alatalo SL, Janckila AJ, Heikkinen JE, Suominen H, et al. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Calcif Tissue Int. 2002;71:20\u20135. https:\/\/doi.org\/10.1007\/s00223-001-2122-7.","journal-title":"Calcif Tissue Int"},{"key":"3804_CR36","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S2213-8587(17)30184-5","volume":"5","author":"R Eastell","year":"2017","unstructured":"Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5:908\u201323. https:\/\/doi.org\/10.1016\/S2213-8587(17)30184-5.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3804_CR37","first-page":"365","volume":"5","author":"HE Albers-Sch\u00f6nberg","year":"1904","unstructured":"Albers-Sch\u00f6nberg HE. R\u00f6ntgenbilder einer seltenen Knockenerkrankung. Munch Med Wochenschr. 1904;5:365\u20138.","journal-title":"Munch Med Wochenschr"},{"key":"3804_CR38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00439-008-0583-8","volume":"124","author":"T Segovia-Silvestre","year":"2009","unstructured":"Segovia-Silvestre T, Neutzsky-Wulff AV, Sorensen MG, Christiansen C, Bollerslev J, Karsdal MA, et al. Advances in osteoclast biology resulting from the study of osteopetrotic mutations. Hum Genet. 2009;124:561\u201377. https:\/\/doi.org\/10.1007\/s00439-008-0583-8.","journal-title":"Hum Genet"},{"key":"3804_CR39","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrendo.2013.137","volume":"9","author":"C Sobacchi","year":"2013","unstructured":"Sobacchi C, Schulz A, Coxon FP, Villa A, Helfrich MH. Osteopetrosis: genetics, treatment and new insights into osteoclast function. Nat Rev Endocrinol. 2013;9:522\u201336. https:\/\/doi.org\/10.1038\/nrendo.2013.137.","journal-title":"Nat Rev Endocrinol"},{"key":"3804_CR40","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/ng2076","volume":"39","author":"C Sobacchi","year":"2007","unstructured":"Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, et al. Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet. 2007;39:960\u20132. https:\/\/doi.org\/10.1038\/ng2076.","journal-title":"Nat Genet"},{"key":"3804_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ajhg.2008.06.015","volume":"83","author":"MM Guerrini","year":"2008","unstructured":"Guerrini MM, Sobacchi C, Cassani B, Abinun M, Kilic SS, Pangrazio A, et al. Human osteoclast-poor Osteopetrosis with Hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet. 2008;83:64\u201376. https:\/\/doi.org\/10.1016\/j.ajhg.2008.06.015.","journal-title":"Am J Hum Genet"},{"key":"3804_CR42","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0002-9440(10)61221-7","volume":"167","author":"K Henriksen","year":"2005","unstructured":"Henriksen K, Gram J, H\u00f8egh-Andersen P, Jemtland R, Ueland T, Dziegiel MH, et al. Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo. Am J Pathol. 2005;167:1341\u20138. https:\/\/doi.org\/10.1016\/S0002-9440(10)61221-7.","journal-title":"Am J Pathol"},{"key":"3804_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1196\/annals.1346.015","volume":"1068","author":"DA Glass","year":"2006","unstructured":"Glass DA, Karsenty G. Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation. Ann N Y Acad Sci. 2006;1068:117\u201330. https:\/\/doi.org\/10.1196\/annals.1346.015.","journal-title":"Ann N Y Acad Sci"},{"key":"3804_CR44","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1056\/NEJMra040952","volume":"351","author":"J Tolar","year":"2004","unstructured":"Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med. 2004;351:2839\u201349. https:\/\/doi.org\/10.1056\/NEJMra040952.","journal-title":"N Engl J Med"},{"key":"3804_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/jmg.2005.036673","volume":"43","author":"A Del Fattore","year":"2006","unstructured":"Del Fattore A, Peruzzi B, Rucci N, Recchia I, Cappariello A, Longo M, et al. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet. 2006;43:315\u201325. https:\/\/doi.org\/10.1136\/jmg.2005.036673.","journal-title":"J Med Genet"},{"key":"3804_CR46","doi-asserted-by":"publisher","unstructured":"Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis. 2011;6. https:\/\/doi.org\/10.1186\/1750-1172-6-80.","DOI":"10.1186\/1750-1172-6-80"},{"key":"3804_CR47","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/humu.20868","volume":"30","author":"FS Kaplan","year":"2009","unstructured":"Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, Carroll L, et al. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat. 2009;30:379\u201390. https:\/\/doi.org\/10.1002\/humu.20868.","journal-title":"Hum Mutat"},{"key":"3804_CR48","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrrheum.2010.122","volume":"6","author":"EM Shore","year":"2010","unstructured":"Shore EM, Kaplan FS. Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol. 2010;6:518\u201327. https:\/\/doi.org\/10.1038\/nrrheum.2010.122.","journal-title":"Nat Rev Rheumatol"},{"key":"3804_CR49","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/jbmr.091110","volume":"25","author":"M Van Dinther","year":"2010","unstructured":"Van Dinther M, Visser N, De Gorter DJJ, Doorn J, Goumans MJ, De Boer J, et al. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation. J Bone Miner Res. 2010;25:1208\u201315. https:\/\/doi.org\/10.1002\/jbmr.091110.","journal-title":"J Bone Miner Res"},{"key":"3804_CR50","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/stem.1633","volume":"32","author":"AL Culbert","year":"2014","unstructured":"Culbert AL, Chakkalakal SA, Theosmy EG, Brennan TA, Kaplan FS, Shore EM. Alk2 regulates early Chondrogenic fate in Fibrodysplasia Ossificans Progressiva heterotopic Endochondral ossification. Stem Cells. 2014;32:1289\u2013300. https:\/\/doi.org\/10.1002\/stem.1633.","journal-title":"Stem Cells"},{"key":"3804_CR51","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/jbmr.1637","volume":"27","author":"SA Chakkalakal","year":"2012","unstructured":"Chakkalakal SA, Zhang D, Culbert AL, Convente MR, Caron RJ, Wright AC, et al. An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva. J Bone Miner Res. 2012;27:1746\u201356. https:\/\/doi.org\/10.1002\/jbmr.1637.","journal-title":"J Bone Miner Res"},{"key":"3804_CR52","doi-asserted-by":"publisher","first-page":"303ra137","DOI":"10.1126\/scitranslmed.aac4358","volume":"7","author":"SJ Hatsell","year":"2015","unstructured":"Hatsell SJ, Idone V, Wolken DMA, Huang L, Kim HJ, Wang L, et al. ACVR1 R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin a. Sci Transl Med. 2015;7:303ra137. https:\/\/doi.org\/10.1126\/scitranslmed.aac4358.","journal-title":"Sci Transl Med"},{"key":"3804_CR53","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.joca.2006.04.001","volume":"14","author":"DC Bauer","year":"2006","unstructured":"Bauer DC, Hunter DJ, Abramson SB, Attur M, Corr M, Felson D, et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthr Cartil. 2006;14:723\u20137. https:\/\/doi.org\/10.1016\/j.joca.2006.04.001.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR54","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","volume":"377","author":"JWJ Bijlsma","year":"2011","unstructured":"Bijlsma JWJ, Berenbaum F, Lafeber FPJG. Osteoarthritis: an update with relevance for clinical practice. Lancet (London, England). 2011;377:2115\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(11)60243-2.","journal-title":"Lancet (London, England)"},{"key":"3804_CR55","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/art.20051","volume":"50","author":"DT Felson","year":"2004","unstructured":"Felson DT, Neogi T. Osteoarthritis: is it a disease of cartilage or of bone? Arthritis Rheum. 2004;50:341\u20134. https:\/\/doi.org\/10.1002\/art.20051.","journal-title":"Arthritis Rheum"},{"key":"3804_CR56","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/art.20124","volume":"50","author":"T Hayami","year":"2004","unstructured":"Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, Destefano J, et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum. 2004;50:1193\u2013206. https:\/\/doi.org\/10.1002\/art.20124.","journal-title":"Arthritis Rheum"},{"key":"3804_CR57","doi-asserted-by":"publisher","first-page":"R152","DOI":"10.1186\/ar3103","volume":"12","author":"M Bellido","year":"2010","unstructured":"Bellido M, Lugo L, Roman-Blas JA, Casta\u00f1eda S, Caeiro JR, Dapia S, et al. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther. 2010;12:R152. https:\/\/doi.org\/10.1186\/ar3103.","journal-title":"Arthritis Res Ther"},{"key":"3804_CR58","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.joca.2011.07.003","volume":"19","author":"M Bellido","year":"2011","unstructured":"Bellido M, Lugo L, Roman-Blas JA, Casta\u00f1eda S, Calvo E, Largo R, et al. Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. Osteoarthr Cartil. 2011;19:1228\u201336. https:\/\/doi.org\/10.1016\/j.joca.2011.07.003.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR59","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bcp.2011.09.018","volume":"83","author":"S Casta\u00f1eda","year":"2012","unstructured":"Casta\u00f1eda S, Roman-Blas JA, Largo R, Herrero-Beaumont G. Subchondral bone as a key target for osteoarthritis treatment. Biochem Pharmacol. 2012;83:315\u201323. https:\/\/doi.org\/10.1016\/j.bcp.2011.09.018.","journal-title":"Biochem Pharmacol"},{"key":"3804_CR60","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00296-009-1183-1","volume":"30","author":"A-C Bay-Jensen","year":"2010","unstructured":"Bay-Jensen A-C, Hoegh-Madsen S, Dam E, Henriksen K, Sondergaard BC, Pastoureau P, et al. Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis? Rheumatol Int. 2010;30:435\u201342. https:\/\/doi.org\/10.1007\/s00296-009-1183-1.","journal-title":"Rheumatol Int"},{"key":"3804_CR61","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1172\/JCI867","volume":"101","author":"JP Mansell","year":"1998","unstructured":"Mansell JP, Bailey AJ. Abnormal cancellous bone collagen metabolism in osteoarthritis. J Clin Invest. 1998;101:1596\u2013603. https:\/\/doi.org\/10.1172\/JCI867.","journal-title":"J Clin Invest"},{"key":"3804_CR62","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/rheumatology\/36.1.16","volume":"36","author":"JP Mansell","year":"1997","unstructured":"Mansell JP, Tarlton JF, Bailey AJ. Biochemical evidence for altered subchondral bone collagen metabolism in osteoarthritis of the hip. Br J Rheumatol. 1997;36:16\u20139 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9117167 (Accessed 7 July 2015).","journal-title":"Br J Rheumatol"},{"key":"3804_CR63","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000213866","volume":"43","author":"AJ Bailey","year":"1997","unstructured":"Bailey AJ, Mansell JP. Do subchondral bone changes exacerbate or precede articular cartilage destruction in osteoarthritis of the elderly? Gerontology. 1997;43:296\u2013304. https:\/\/doi.org\/10.1159\/000213866.","journal-title":"Gerontology."},{"key":"3804_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/0049-0172(90)90045-H","volume":"20","author":"MA Davis","year":"1990","unstructured":"Davis MA, Ettinger WH, Neuhaus JM. Obesity and osteoarthritis of the knee: evidence from the National Health and nutrition examination survey (NHANES I). Semin Arthritis Rheum. 1990;20:34\u201341 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2287947.","journal-title":"Semin Arthritis Rheum"},{"key":"3804_CR65","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S1357-2725(02)00312-6","volume":"35","author":"JP Mansell","year":"2003","unstructured":"Mansell JP, Bailey AJ. Increased metabolism of bone collagen in post-menopausal female osteoporotic femoral heads. Int J Biochem Cell Biol. 2003;35:522\u20139 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12565712.","journal-title":"Int J Biochem Cell Biol"},{"key":"3804_CR66","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/rheumatology\/keg373","volume":"42","author":"DJ Hunter","year":"2003","unstructured":"Hunter DJ, Hart D, Snieder H, Bettica P, Swaminathan R, Spector TD. Evidence of altered bone turnover, vitamin D and calcium regulation with knee osteoarthritis in female twins. Rheumatology (Oxford). 2003;42:1311\u20136. https:\/\/doi.org\/10.1093\/rheumatology\/keg373.","journal-title":"Rheumatology (Oxford)"},{"key":"3804_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11926-003-0078-5","volume":"5","author":"DJ Hunter","year":"2003","unstructured":"Hunter DJ, Spector TD. The role of bone metabolism in osteoarthritis. Curr Rheumatol Rep. 2003;5:15\u20139 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12590880.","journal-title":"Curr Rheumatol Rep"},{"key":"3804_CR68","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/ard.52.8.557","volume":"52","author":"P Dieppe","year":"1993","unstructured":"Dieppe P, Cushnaghan J, Young P, Kirwan J. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis. 1993;52:557\u201363. https:\/\/doi.org\/10.1136\/ard.52.8.557.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR69","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1172\/JCI4853","volume":"102","author":"F Nelson","year":"1998","unstructured":"Nelson F, Dahlberg L, Laverty S, Reiner A, Pidoux I, Ionescu M, et al. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest. 1998;102:2115\u201325. https:\/\/doi.org\/10.1172\/JCI4853.","journal-title":"J Clin Invest"},{"key":"3804_CR70","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/art.20136","volume":"50","author":"J Rogers","year":"2004","unstructured":"Rogers J, Shepstone L, Dieppe P. Is osteoarthritis a systemic disorder of bone? Arthritis Rheum. 2004;50:452\u20137. https:\/\/doi.org\/10.1002\/art.20136.","journal-title":"Arthritis Rheum"},{"key":"3804_CR71","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00223-010-9404-x","volume":"87","author":"E Donnelly","year":"2010","unstructured":"Donnelly E, Chen DX, Boskey AL, Baker SP, van der Meulen MCH. Contribution of mineral to bone structural behavior and tissue mechanical properties. Calcif Tissue Int. 2010;87:450\u201360. https:\/\/doi.org\/10.1007\/s00223-010-9404-x.","journal-title":"Calcif Tissue Int"},{"key":"3804_CR72","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0736-0266(01)00012-2","volume":"19","author":"JS Day","year":"2001","unstructured":"Day JS, Ding M, van der Linden JC, Hvid I, Sumner DR, Weinans H. A decreased subchondral trabecular bone tissue elastic modulus is associated with pre-arthritic cartilage damage. J Orthop Res. 2001;19:914\u20138. https:\/\/doi.org\/10.1016\/S0736-0266(01)00012-2.","journal-title":"J Orthop Res"},{"key":"3804_CR73","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00256-008-0446-3","volume":"37","author":"MS Taljanovic","year":"2008","unstructured":"Taljanovic MS, Graham AR, Benjamin JB, Gmitro AF, Krupinski EA, Schwartz SA, et al. Bone marrow edema pattern in advanced hip osteoarthritis: quantitative assessment with magnetic resonance imaging and correlation with clinical examination, radiographic findings, and histopathology. Skeletal Radiol. 2008;37:423\u201331. https:\/\/doi.org\/10.1007\/s00256-008-0446-3.","journal-title":"Skeletal Radiol"},{"key":"3804_CR74","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/1471-2474-12-217","volume":"12","author":"JB Driban","year":"2011","unstructured":"Driban JB, Lo GH, Lee JY, Ward RJ, Miller E, Pang J, et al. Quantitative bone marrow lesion size in osteoarthritic knees correlates with cartilage damage and predicts longitudinal cartilage loss. BMC Musculoskelet Disord. 2011;12:217. https:\/\/doi.org\/10.1186\/1471-2474-12-217.","journal-title":"BMC Musculoskelet Disord"},{"key":"3804_CR75","doi-asserted-by":"publisher","unstructured":"Kuttapitiya A, Assi L, Laing K, Hing C, Mitchell P, Whitley G, et al. Microarray analysis of bone marrow lesions in osteoarthritis demonstrates upregulation of genes implicated in osteochondral turnover, neurogenesis and inflammation. Ann Rheum Dis. 2017annrheumdis-2017-211396. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211396.","DOI":"10.1136\/annrheumdis-2017-211396"},{"key":"3804_CR76","doi-asserted-by":"publisher","unstructured":"He Y, Manon-Jensen T, Arendt-Nielsen L, Petersen KK, Christiansen T, Samuels J, et al. Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis. Osteoarthr Cartil. 2019. https:\/\/doi.org\/10.1016\/j.joca.2019.01.001.","DOI":"10.1016\/j.joca.2019.01.001"},{"key":"3804_CR77","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1359\/jbmr.2000.15.1.82","volume":"15","author":"J \u00c1lvarez","year":"2000","unstructured":"\u00c1lvarez J, Balb\u00edn M, Santos F, Fern\u00e1ndez M, Ferrando S, L\u00f3pez JM. Different Bone growth rates are associated with changes in the expression pattern of types II and X collagens and collagenase 3 in proximal growth plates of the rat tibia. J Bone Miner Res. 2000;15:82\u201394. https:\/\/doi.org\/10.1359\/jbmr.2000.15.1.82.","journal-title":"J Bone Miner Res"},{"key":"3804_CR78","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.joca.2004.08.008","volume":"12","author":"X Wang","year":"2004","unstructured":"Wang X, Manner PA, Horner A, Shum L, Tuan RS, Nuckolls GH. Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthr Cartil. 2004;12:963\u201373. https:\/\/doi.org\/10.1016\/j.joca.2004.08.008.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR79","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.joca.2011.12.003","volume":"20","author":"PM van der Kraan","year":"2012","unstructured":"van der Kraan PM, van den Berg WB. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthr Cartil. 2012;20:223\u201332. https:\/\/doi.org\/10.1016\/j.joca.2011.12.003.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR80","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1046\/j.1469-7580.2003.00158.x","volume":"202","author":"S Zoricic","year":"2003","unstructured":"Zoricic S, Maric I, Bobinac D, Vukicevic S. Expression of bone morphogenetic proteins and cartilage-derived morphogenetic proteins during osteophyte formation in humans. J Anat. 2003;202:269\u201377 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12713267.","journal-title":"J Anat"},{"key":"3804_CR81","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.joca.2007.02.005","volume":"15","author":"EN Blaney Davidson","year":"2007","unstructured":"Blaney Davidson EN, van der Kraan PM, van den Berg WB. TGF-beta and osteoarthritis. Osteoarthr Cartil. 2007;15:597\u2013604. https:\/\/doi.org\/10.1016\/j.joca.2007.02.005.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR82","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrrheum.2016.219","volume":"13","author":"PM van der Kraan","year":"2017","unstructured":"van der Kraan PM. The changing role of TGF\u03b2 in healthy, ageing and osteoarthritic joints. Nat Rev Rheumatol. 2017;13:155\u201363. https:\/\/doi.org\/10.1038\/nrrheum.2016.219.","journal-title":"Nat Rev Rheumatol"},{"key":"3804_CR83","doi-asserted-by":"publisher","first-page":"e0219980","DOI":"10.1371\/journal.pone.0219980","volume":"14","author":"JPM Blair","year":"2019","unstructured":"Blair JPM, Bager C, Platt A, Karsdal M, Bay-Jensen A-C. Identification of pathological RA endotypes using blood-based biomarkers reflecting tissue metabolism. A retrospective and explorative analysis of two phase III RA studies. PLoS One. 2019;14:e0219980. https:\/\/doi.org\/10.1371\/journal.pone.0219980.","journal-title":"PLoS One"},{"key":"3804_CR84","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1002\/art.38739","volume":"66","author":"JL Huebner","year":"2014","unstructured":"Huebner JL, Bay-Jensen AC, Huffman KM, He Y, Leeming DJ, McDaniel GE, et al. Alpha C-Telopeptide of type I collagen is associated with Subchondral Bone turnover and predicts progression of joint space narrowing and osteophytes in osteoarthritis. Arthritis Rheumatol. 2014;66:2440\u20139. https:\/\/doi.org\/10.1002\/art.38739.","journal-title":"Arthritis Rheumatol"},{"key":"3804_CR85","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.joca.2013.10.020","volume":"22","author":"AS Siebuhr","year":"2014","unstructured":"Siebuhr AS, Petersen KK, Arendt-Nielsen L, Egsgaard LL, Eskehave T, Christiansen C, et al. Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover. Osteoarthr Cartil. 2014;22:44\u201350. https:\/\/doi.org\/10.1016\/j.joca.2013.10.020.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR86","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.joca.2017.01.002","volume":"25","author":"LN Nwosu","year":"2017","unstructured":"Nwosu LN, Allen M, Wyatt L, Huebner JL, Chapman V, Walsh DA, et al. Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA. Osteoarthr Cartil. 2017;25:858\u201365. https:\/\/doi.org\/10.1016\/j.joca.2017.01.002.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR87","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00776-014-0535-1","volume":"19","author":"N Tanishi","year":"2014","unstructured":"Tanishi N, Yamagiwa H, Hayami T, Mera H, Koga Y, Omori G, et al. Usefulness of urinary CTX-II and NTX-I in evaluating radiological knee osteoarthritis : the Matsudai knee osteoarthritis survey. J Orthop Sci. 2014;19:429\u201336. https:\/\/doi.org\/10.1007\/s00776-014-0535-1.","journal-title":"J Orthop Sci"},{"key":"3804_CR88","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1002\/art.21366","volume":"52","author":"P Garnero","year":"2005","unstructured":"Garnero P, Peterfy C, Zaim S, Schoenharting M. Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study. Arthritis Rheum. 2005;52:2822\u20139. https:\/\/doi.org\/10.1002\/art.21366.","journal-title":"Arthritis Rheum"},{"key":"3804_CR89","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.joca.2015.03.023","volume":"23","author":"WE Van Spil","year":"2015","unstructured":"Van Spil WE, Welsing PMJ, Bierma-Zeinstra SMA, Bijlsma JWJ, Roorda LD, Cats HA, et al. The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK. Osteoarthr Cartil. 2015;23:1388\u201397. https:\/\/doi.org\/10.1016\/j.joca.2015.03.023.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR90","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.joca.2008.07.009","volume":"17","author":"EB Dam","year":"2009","unstructured":"Dam EB, Byrjalsen I, Karsdal MA, Qvist P, Christiansen C. Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI. Osteoarthr Cartil. 2009;17:384\u20139. https:\/\/doi.org\/10.1016\/j.joca.2008.07.009.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR91","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/art.20332","volume":"50","author":"M Reijman","year":"2004","unstructured":"Reijman M, Hazes JMW, Bierma-Zeinstra SMA, Koes BW, Christgau S, Christiansen C, et al. A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum. 2004;50:2471\u20138. https:\/\/doi.org\/10.1002\/art.20332.","journal-title":"Arthritis Rheum"},{"key":"3804_CR92","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.joca.2009.06.001","volume":"17","author":"MF Sowers","year":"2009","unstructured":"Sowers MF, Karvonen-Gutierrez CA, Yosef M, Jannausch M, Jiang Y, Garnero P, et al. Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women. Osteoarthr Cartil. 2009;17:1609\u201314. https:\/\/doi.org\/10.1016\/j.joca.2009.06.001.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR93","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/art.1780390116","volume":"39","author":"D Mulherin","year":"1996","unstructured":"Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 1996;39:115\u201324. https:\/\/doi.org\/10.1002\/art.1780390116.","journal-title":"Arthritis Rheum"},{"key":"3804_CR94","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/ard.2005.042895","volume":"65","author":"KM Jordan","year":"2006","unstructured":"Jordan KM, Syddall HE, Garnero P, Gineyts E, Dennison EM, Sayer AA, et al. Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. Ann Rheum Dis. 2006;65:871\u20137. https:\/\/doi.org\/10.1136\/ard.2005.042895.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR95","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.clinbiochem.2011.01.001","volume":"44","author":"A-C Bay-Jensen","year":"2011","unstructured":"Bay-Jensen A-C, Liu Q, Byrjalsen I, Li Y, Wang J, Pedersen C, et al. Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM--increased serum CIIM in subjects with severe radiographic osteoarthritis. Clin Biochem. 2011;44:423\u20139. https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.01.001.","journal-title":"Clin Biochem"},{"key":"3804_CR96","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.joca.2010.01.012","volume":"18","author":"WE van Spil","year":"2010","unstructured":"van Spil WE, DeGroot J, Lems WF, Oostveen JCM, Lafeber FPJG. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthr Cartil. 2010;18:605\u201312. https:\/\/doi.org\/10.1016\/j.joca.2010.01.012.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190251","volume":"12","author":"HN Daghestani","year":"2017","unstructured":"Daghestani HN, Jordan JM, Renner JB, Doherty M, Wilson AG, Kraus VB. Serum N-propeptide of collagen IIA (PIIANP) as a marker of radiographic osteoarthritis burden. PLoS One. 2017;12:e0190251. https:\/\/doi.org\/10.1371\/journal.pone.0190251.","journal-title":"PLoS One"},{"key":"3804_CR98","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/rheumatology\/kel409","volume":"46","author":"M Sharif","year":"2007","unstructured":"Sharif M, Kirwan J, Charni N, Sandell LJ, Whittles C, Garnero P. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression. Rheumatology (Oxford). 2007;46:938\u201343. https:\/\/doi.org\/10.1093\/rheumatology\/kel409.","journal-title":"Rheumatology (Oxford)"},{"key":"3804_CR99","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1385\/1-59259-821-8:025","volume":"101","author":"J-C Rousseau","year":"2004","unstructured":"Rousseau J-C, Sandell LJ, Delmas PD, Garnero P. Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptide. Methods Mol Med. 2004;101:25\u201337. https:\/\/doi.org\/10.1385\/1-59259-821-8:025.","journal-title":"Methods Mol Med"},{"key":"3804_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms19113485","volume":"19","author":"Y Luo","year":"2018","unstructured":"Luo Y, He Y, Reker D, Gudmann NS, Henriksen K, Simonsen O, et al. A novel high sensitivity type II collagen blood-based biomarker, PRO-C2, for assessment of cartilage formation. Int J Mol Sci. 2018;19:1\u201315. https:\/\/doi.org\/10.3390\/ijms19113485.","journal-title":"Int J Mol Sci"},{"key":"3804_CR101","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.joca.2014.02.930","volume":"22","author":"FM Germaschewski","year":"2014","unstructured":"Germaschewski FM, Matheny CJ, Larkin J, Liu F, Thomas LR, Saunders JS, et al. Quantitation OF ARGS aggrecan fragments in synovial fluid, serum and urine from osteoarthritis patients. Osteoarthr Cartil. 2014;22:690\u20137. https:\/\/doi.org\/10.1016\/j.joca.2014.02.930.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR102","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1002\/art.21977","volume":"54","author":"SY Kong","year":"2006","unstructured":"Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Arthritis Rheum. 2006;54:2496\u2013504. https:\/\/doi.org\/10.1002\/art.21977.","journal-title":"Arthritis Rheum"},{"key":"3804_CR103","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/03009740601154186","volume":"36","author":"FA Fernandes","year":"2007","unstructured":"Fernandes FA, Pucinelli MLC, da Silva NP, Feldman D. Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation. Scand J Rheumatol. 2007;36:211\u20135. https:\/\/doi.org\/10.1080\/03009740601154186.","journal-title":"Scand J Rheumatol"},{"key":"3804_CR104","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.joca.2013.04.009","volume":"21","author":"O Blumenfeld","year":"2013","unstructured":"Blumenfeld O, Williams FMK, Hart DJ, Spector TD, Arden N, Livshits G. Association between cartilage and bone biomarkers and incidence of radiographic knee osteoarthritis (RKOA) in UK females: a prospective study. Osteoarthr Cartil. 2013;21:923\u20139. https:\/\/doi.org\/10.1016\/j.joca.2013.04.009.","journal-title":"Osteoarthr Cartil"},{"key":"3804_CR105","doi-asserted-by":"publisher","unstructured":"Bay-Jensen AC, Thudium CS, Mobasheri A. Development and use of biochemical markers in osteoarthritis. Curr Opin Rheumatol. 2017;1. https:\/\/doi.org\/10.1097\/BOR.0000000000000467.","DOI":"10.1097\/BOR.0000000000000467"},{"key":"3804_CR106","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.clinbiochem.2011.01.001","volume":"44","author":"AC Bay-Jensen","year":"2011","unstructured":"Bay-Jensen AC, Liu Q, Byrjalsen I, Li Y, Wang J, Pedersen C, et al. Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM-increased serum CIIM in subjects with severe radiographic osteoarthritis. Clin Biochem. 2011;44:423\u20139. https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.01.001.","journal-title":"Clin Biochem"},{"key":"3804_CR107","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/1471-2474-15-309","volume":"15","author":"Y He","year":"2014","unstructured":"He Y, Siebuhr AS, Brandt-Hansen NU, Wang J, Su D, Zheng Q, et al. Type X collagen levels are elevated in serum from human osteoarthritis patients and associated with biomarkers of cartilage degradation and inflammation. BMC Musculoskelet Disord. 2014;15:309. https:\/\/doi.org\/10.1186\/1471-2474-15-309.","journal-title":"BMC Musculoskelet Disord"},{"key":"3804_CR108","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S8756-3282(00)00248-9","volume":"26","author":"S Christgau","year":"2000","unstructured":"Christgau S, Bitsch-Jensen O, Hanover Bjarnason N, Gamwell Henriksen E, Qvist P, Alexandersen P, et al. Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy. Bone. 2000;26:505\u201311. https:\/\/doi.org\/10.1016\/S8756-3282(00)00248-9.","journal-title":"Bone"},{"key":"3804_CR109","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00198-007-0462-5","volume":"19","author":"I Byrjalsen","year":"2008","unstructured":"Byrjalsen I, Leeming DJ, Qvist P, Christiansen C, Karsdal MA. Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies. Osteoporos Int. 2008;19:339\u201348. https:\/\/doi.org\/10.1007\/s00198-007-0462-5.","journal-title":"Osteoporos Int"},{"key":"3804_CR110","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00198-006-0298-4","volume":"18","author":"K Henriksen","year":"2007","unstructured":"Henriksen K, Leeming DJ, Byrjalsen I, Nielsen RH, Sorensen MG, Dziegiel MH, et al. Osteoclasts prefer aged bone. Osteoporos Int. 2007;18:751\u20139. https:\/\/doi.org\/10.1007\/s00198-006-0298-4.","journal-title":"Osteoporos Int"},{"key":"3804_CR111","doi-asserted-by":"publisher","first-page":"18789","DOI":"10.3390\/ijms151018789","volume":"15","author":"N Gudmann","year":"2014","unstructured":"Gudmann N, Wang J, Hoielt S, Chen P, Siebuhr A, He Y, et al. Cartilage turnover reflected by metabolic processing of type II collagen: a novel marker of anabolic function in chondrocytes. Int J Mol Sci. 2014;15:18789\u2013803. https:\/\/doi.org\/10.3390\/ijms151018789.","journal-title":"Int J Mol Sci"},{"key":"3804_CR112","doi-asserted-by":"publisher","first-page":"e035101","DOI":"10.1136\/bmjopen-2019-035101","volume":"10","author":"EM van Helvoort","year":"2020","unstructured":"van Helvoort EM, van Spil WE, Jansen MP, Welsing PMJ, Kloppenburg M, Loef M, et al. Cohort profile: the applied public-private research enabling OsteoArthritis clinical headway (IMI-APPROACH) study: a 2-year, European, cohort study to describe, validate and predict phenotypes of osteoarthritis using clinical, imaging and biochemical mark. BMJ Open. 2020;10:e035101. https:\/\/doi.org\/10.1136\/bmjopen-2019-035101.","journal-title":"BMJ Open"},{"key":"3804_CR113","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bcp.2019.02.037","volume":"165","author":"WE Van Spil","year":"2019","unstructured":"Van Spil WE, Kubassova O, Boesen M, Bay-Jensen AC, Mobasheri A. Osteoarthritis phenotypes and novel therapeutic targets. Biochem Pharmacol. 2019;165:41\u20138. https:\/\/doi.org\/10.1016\/j.bcp.2019.02.037.","journal-title":"Biochem Pharmacol"},{"key":"3804_CR114","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2018-213864","volume":"78","author":"F Berenbaum","year":"2019","unstructured":"Berenbaum F. Deep phenotyping of osteoarthritis: a step forward. Ann Rheum Dis. 2019;78:3\u20135. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213864.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR115","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.7748\/phc2011.11.21.9.29.c8797","volume":"365","author":"I McInnes","year":"2011","unstructured":"McInnes I, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205\u2013019 https:\/\/doi.org\/10.7748\/phc2011.11.21.9.29.c8797.","journal-title":"N Engl J Med"},{"key":"3804_CR116","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46:183\u201396. https:\/\/doi.org\/10.1016\/j.immuni.2017.02.006.","journal-title":"Immunity."},{"key":"3804_CR117","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/ar67","volume":"2","author":"SR Goldring","year":"2000","unstructured":"Goldring SR, Gravallese EM. Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res. 2000;2:33\u20137. https:\/\/doi.org\/10.1186\/ar67.","journal-title":"Arthritis Res"},{"key":"3804_CR118","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.0105-2896.2009.00857.x","volume":"233","author":"NC Walsh","year":"2010","unstructured":"Walsh NC, Gravallese EM. Bone remodeling in rheumatic disease: a question of balance. Immunol Rev. 2010;233:301\u201312. https:\/\/doi.org\/10.1111\/j.0105-2896.2009.00857.x.","journal-title":"Immunol Rev"},{"key":"3804_CR119","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/art.1780270902","volume":"27","author":"M Bromley","year":"1984","unstructured":"Bromley M, Woolley DE. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum. 1984;27:968\u201375. https:\/\/doi.org\/10.1002\/art.1780270902.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"3804_CR120","doi-asserted-by":"publisher","first-page":"i72","DOI":"10.1136\/ard.59.suppl","volume":"59","author":"SR Goldring","year":"2000","unstructured":"Goldring SR. The final pathogenetic steps in focal bone erosions in rheumatoid arthritis. Ann Rheum Dis. 2000;59(Suppl 1):i72\u20134. https:\/\/doi.org\/10.1136\/ard.59.suppl.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR121","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T","volume":"43","author":"E Romas","year":"2000","unstructured":"Romas E, Bakharevski O, Hards DK, Kartsogiannis V, Quinn JMW, Ryan PFJ, et al. Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum. 2000;43:821\u20136. https:\/\/doi.org\/10.1002\/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T.","journal-title":"Arthritis Rheum"},{"key":"3804_CR122","first-page":"751","volume":"13","author":"T Kuratani","year":"1998","unstructured":"Kuratani T, Nagata K, Kukita T, Hotokebuchi T, Nakasima A, Iijima T. Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover. Histol Histopathol. 1998;13:751\u20139.","journal-title":"Histol Histopathol"},{"key":"3804_CR123","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10238-010-0117-2","volume":"11","author":"N Maruotti","year":"2011","unstructured":"Maruotti N, Grano M, Colucci S, D\u2019Onofrio F, Cantatore FP. Osteoclastogenesis and arthritis. Clin Exp Med. 2011;11:137\u201345. https:\/\/doi.org\/10.1007\/s10238-010-0117-2.","journal-title":"Clin Exp Med"},{"key":"3804_CR124","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.molmed.2014.03.003","volume":"20","author":"JO Manilay","year":"2014","unstructured":"Manilay JO, Zouali M. Tight relationships between B lymphocytes and the skeletal system. Trends Mol Med. 2014;20:405\u201312. https:\/\/doi.org\/10.1016\/j.molmed.2014.03.003.","journal-title":"Trends Mol Med"},{"key":"3804_CR125","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/art.39489","volume":"68","author":"N Meednu","year":"2016","unstructured":"Meednu N, Zhang H, Owen T, Sun W, Wang V, Cistrone C, et al. Production of RANKL by memory B cells: a link between B cells and Bone erosion in rheumatoid arthritis. Arthritis Rheumatol. 2016;68:805\u201316. https:\/\/doi.org\/10.1002\/art.39489.","journal-title":"Arthritis Rheumatol"},{"key":"3804_CR126","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.bone.2010.10.167","volume":"48","author":"M Durand","year":"2011","unstructured":"Durand M, Boire G, Komarova SV, Dixon SJ, Sims SM, Harrison RE, et al. The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis - the in vitro osteoclast differentiation in arthritis (IODA) study. Bone. 2011;48:588\u201396. https:\/\/doi.org\/10.1016\/j.bone.2010.10.167.","journal-title":"Bone."},{"key":"3804_CR127","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11914-013-0183-y","volume":"12","author":"R Baum","year":"2014","unstructured":"Baum R, Gravallese EM. Impact of inflammation on the osteoblast in rheumatic diseases. Curr Osteoporos Rep. 2014;12:9\u201316. https:\/\/doi.org\/10.1007\/s11914-013-0183-y.","journal-title":"Curr Osteoporos Rep"},{"key":"3804_CR128","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007;13:156\u201363. https:\/\/doi.org\/10.1038\/nm1538.","journal-title":"Nat Med"},{"key":"3804_CR129","doi-asserted-by":"publisher","first-page":"330ra35 LP-330r","DOI":"10.1126\/scitranslmed.aac4351","volume":"8","author":"C Wehmeyer","year":"2016","unstructured":"Wehmeyer C, Frank S, Beckmann D, B\u00f6ttcher M, Cromme C, K\u00f6nig U, et al. Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction. Sci Transl Med. 2016;8:330ra35 LP-330ra35.","journal-title":"Sci Transl Med"},{"key":"3804_CR130","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/art.20382","volume":"50","author":"NA Sims","year":"2004","unstructured":"Sims NA, Green JR, Glatt M, Schlict S, Martin TJ, Gillespie MT, et al. Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis. Arthritis Rheum. 2004;50:2338\u201346. https:\/\/doi.org\/10.1002\/art.20382.","journal-title":"Arthritis Rheum"},{"key":"3804_CR131","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00296-017-3720-7","volume":"37","author":"M Tada","year":"2017","unstructured":"Tada M, Inui K, Sugioka Y, Mamoto K, Okano T, Anno S, et al. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study. Rheumatol Int. 2017;37:999\u20131005. https:\/\/doi.org\/10.1007\/s00296-017-3720-7.","journal-title":"Rheumatol Int"},{"key":"3804_CR132","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/annrheumdis-2018-214827","volume":"78","author":"T Takeuchi","year":"2019","unstructured":"Takeuchi T, Tanaka Y, Soen S, Yamanaka H, Yoneda T, Tanaka S, et al. Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase. Ann Rheum Dis. 2019;78:899\u2013907. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214827.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR133","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/art.1780100504","volume":"10","author":"PD Saville","year":"1967","unstructured":"Saville PD, Kharmosh O. Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids. Arthritis Rheum. 1967;10:423\u201330. https:\/\/doi.org\/10.1002\/art.1780100504.","journal-title":"Arthritis Rheum"},{"key":"3804_CR134","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/ard.44.6.406","volume":"44","author":"OS Als","year":"1985","unstructured":"Als OS, Gotfredsen A, Riis BJ, Christiansen C. Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis? Ann Rheum Dis. 1985;44:406\u201311. https:\/\/doi.org\/10.1136\/ard.44.6.406.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR135","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest. 2012;122:1791\u2013802. https:\/\/doi.org\/10.1172\/JCI60975.","journal-title":"J Clin Invest"},{"key":"3804_CR136","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/ard.2004.033571","volume":"64","author":"J R\u00f6nnelid","year":"2005","unstructured":"R\u00f6nnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, et al. Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis. 2005;64:1744\u20139. https:\/\/doi.org\/10.1136\/ard.2004.033571.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR137","doi-asserted-by":"publisher","first-page":"R949","DOI":"10.1186\/ar1767","volume":"7","author":"AHM van der Helm-van Mil","year":"2005","unstructured":"van der Helm-van Mil AHM, Verpoort KN, Breedveld FC, Toes REM, Huizinga TWJ. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther. 2005;7:R949\u201358. https:\/\/doi.org\/10.1186\/ar1767.","journal-title":"Arthritis Res Ther"},{"key":"3804_CR138","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13075-016-1116-9","volume":"18","author":"S Bugatti","year":"2016","unstructured":"Bugatti S, Bogliolo L, Vitolo B, Manzo A, Montecucco C, Caporali R. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis. Arthritis Res Ther. 2016;18:226. https:\/\/doi.org\/10.1186\/s13075-016-1116-9.","journal-title":"Arthritis Res Ther"},{"key":"3804_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0188454","volume":"12","author":"YM Chen","year":"2017","unstructured":"Chen YM, Chen HH, Huang WN, Liao TL, Chen JP, Chao WC, et al. Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis. PLoS One. 2017;12:1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0188454.","journal-title":"PLoS One"},{"key":"3804_CR140","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00223-017-0253-8","volume":"101","author":"G Orsolini","year":"2017","unstructured":"Orsolini G, Caimmi C, Viapiana O, Idolazzi L, Fracassi E, Gatti D, et al. Titer-dependent effect of anti-Citrullinated protein antibodies on systemic Bone mass in rheumatoid arthritis patients. Calcif Tissue Int. 2017;101:17\u201323. https:\/\/doi.org\/10.1007\/s00223-017-0253-8.","journal-title":"Calcif Tissue Int"},{"key":"3804_CR141","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(94)91049-9","volume":"344","author":"AKS Gough","year":"1994","unstructured":"Gough AKS, Emery P, Holder RL, Lilley J, Eyre S. Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994;344:23\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(94)91049-9.","journal-title":"Lancet."},{"key":"3804_CR142","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1136\/ard.44.9.580","volume":"44","author":"PN Sambrook","year":"1985","unstructured":"Sambrook PN, Ansell BM, Foster S, Gumpel JM, Hesp R, Reeve J. Bone turnover in early rheumatoid arthritis . 2 . Longitudinal bone density studies rheumatoid control arth ritis subjects. Ann Rheum Dis. 1985;44:580\u20134.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR143","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3899\/jrheum.080180","volume":"36","author":"SW Syversen","year":"2009","unstructured":"Syversen SW, Goll GL, van der Heijde D, Landew\u00e9 R, Gaarder PI, Odeg\u00e5rd S, et al. Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression. J Rheumatol. 2009;36:266\u201372. https:\/\/doi.org\/10.3899\/jrheum.080180.","journal-title":"J Rheumatol"},{"key":"3804_CR144","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13075-015-0913-x","volume":"18","author":"AC Bay-Jensen","year":"2016","unstructured":"Bay-Jensen AC, Platt A, Siebuhr AS, Christiansen C, Byrjalsen I, Karsdal MA. Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study. Arthritis Res Ther. 2016;18:13. https:\/\/doi.org\/10.1186\/s13075-015-0913-x.","journal-title":"Arthritis Res Ther"},{"key":"3804_CR145","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/ard.2007.076604","volume":"67","author":"F Chopin","year":"2008","unstructured":"Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, et al. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:353\u20137. https:\/\/doi.org\/10.1136\/ard.2007.076604.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR146","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/art.25053","volume":"62","author":"P Garnero","year":"2010","unstructured":"Garnero P, Thompson E, Woodworth T, Smolen JS. Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of th. Arthritis Rheum. 2010;62:33\u201343. https:\/\/doi.org\/10.1002\/art.25053.","journal-title":"Arthritis Rheum"},{"key":"3804_CR147","doi-asserted-by":"publisher","first-page":"R86","DOI":"10.1186\/ar4266","volume":"15","author":"A Siebuhr","year":"2013","unstructured":"Siebuhr A, Bay-Jensen AC, Leeming DJ, Plat A, Byrjalsen I, Christiansen C, et al. Serological identification of fast progressors of structural damage with rheumatoid arthritis. Arthritis Res Ther. 2013;15:R86. https:\/\/doi.org\/10.1186\/ar4266.","journal-title":"Arthritis Res Ther"},{"key":"3804_CR148","first-page":"1250","volume":"26","author":"A Al-Awadhi","year":"1999","unstructured":"Al-Awadhi A, Olusi S, Al-Zaid N, Prabha K. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis. J Rheumatol. 1999;26:1250\u20136 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10381038.","journal-title":"J Rheumatol"},{"key":"3804_CR149","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1749-6632.2002.tb04254.x","volume":"966","author":"B Seriolo","year":"2002","unstructured":"Seriolo B, Ferretti V, Sulli A, Caratto E, Fasciolo D, Cutolo M. Serum osteocalcin levels in premenopausal rheumatoid arthritis patients. Ann N Y Acad Sci. 2002;966:502\u20137 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12114311.","journal-title":"Ann N Y Acad Sci"},{"key":"3804_CR150","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1002\/art.22923","volume":"56","author":"S Young-Min","year":"2007","unstructured":"Young-Min S, Cawston T, Marshall N, Coady D, Christgau S, Saxne T, et al. Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers. Arthritis Rheum. 2007;56:3236\u201347. https:\/\/doi.org\/10.1002\/art.22923.","journal-title":"Arthritis Rheum"},{"key":"3804_CR151","unstructured":"Christensen AF, Lottenburger T, Lindegaard H, Christgau S, H\u00f8rslev-Petersen K, Junker P. Differential association of the N-propeptide of collagen IIA (PIIANP) and collagen II C-telopeptide (CTX-II) with synovitis and erosions in early and longstanding rheumatoid arthritis. Clin Exp Rheumatol. n.d.;27:307\u201314 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19473573."},{"key":"3804_CR152","unstructured":"Gudmann NS, Junker P, Juhl P, Thudium CS, Siebuhr AS, Byrjalsen I, et al. Type IV collagen metabolism is associated with disease activity, radiographic progression and response to tocilizumab in rheumatoid arthritis. Clin Exp Rheumatol. 2018; http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29745884."},{"key":"3804_CR153","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1002\/art.10616","volume":"46","author":"P Garnero","year":"2002","unstructured":"Garnero P, Landew\u00e9 R, Boers M, Verhoeven A, Van Der Linden S, Christgau S, et al. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum. 2002;46:2847\u201356. https:\/\/doi.org\/10.1002\/art.10616.","journal-title":"Arthritis Rheum"},{"key":"3804_CR154","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S8756-3282(00)00235-0","volume":"26","author":"ML Sassi","year":"2000","unstructured":"Sassi ML, Eriksen H, Risteli L, Niemi S, Mansell J, Gowen M, et al. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Bone. 2000;26:367\u201373. https:\/\/doi.org\/10.1016\/S8756-3282(00)00235-0.","journal-title":"Bone."},{"key":"3804_CR155","doi-asserted-by":"publisher","first-page":"R86","DOI":"10.1186\/ar4266","volume":"15","author":"AS Siebuhr","year":"2013","unstructured":"Siebuhr AS, Bay-jensen AC, Leeming DJ, Plat A, Byrjalsen I, Christiansen C, et al. Serological identification of fast progressors of structural damage with rheumatoid arthritis. Arthritis Res Ther. 2013;15:R86. https:\/\/doi.org\/10.1186\/ar4266.","journal-title":"Arthritis Res Ther"},{"key":"3804_CR156","doi-asserted-by":"publisher","unstructured":"C.F. Kjelgaard-Petersen, A. Platt, M. Braddock, M.A. Jenkins, K. Musa, E. Graham, T. Gantzel, G. Slynn, M.E. Weinblatt, M.A. Karsdal, C.S. Thudium, A. C. Bay-Jensen, Translational biomarkers and ex vivo models of joint tissues as a tool for drug development in rheumatoid arthritis, Arthritis Rheumatol. (2018) 0\u20132. https:\/\/doi.org\/10.1002\/art.40527.","DOI":"10.1002\/art.40527"},{"key":"3804_CR157","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/ard.2004.031740","volume":"64","author":"DJ Veale","year":"2005","unstructured":"Veale DJ, Ritchlin C, FitzGerald O. Immunopathology of psoriasis and psoriatic arthritis. Ann Rheum Dis. 2005;64:26\u20139. https:\/\/doi.org\/10.1136\/ard.2004.031740.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR158","doi-asserted-by":"publisher","first-page":"65","DOI":"10.15557\/JoU.2016.0007","volume":"16","author":"I Sudo\u0142-Szopi\u0144ska","year":"2016","unstructured":"Sudo\u0142-Szopi\u0144ska I, Matuszewska G, Kwiatkowska B, Praco\u0144 G. Diagnostic imaging of psoriatic arthritis. Part I: etiopathogenesis, classifications and radiographic features. J Ultrason. 2016;16:65\u201377. https:\/\/doi.org\/10.15557\/JoU.2016.0007.","journal-title":"J Ultrason"},{"key":"3804_CR159","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/BOR.0000000000000232","volume":"28","author":"A Paine","year":"2016","unstructured":"Paine A, Ritchlin C. Bone remodeling in psoriasis and psoriatic arthritis: an update. Curr Opin Rheumatol. 2016;28:66\u201375. https:\/\/doi.org\/10.1097\/BOR.0000000000000232.","journal-title":"Curr Opin Rheumatol"},{"key":"3804_CR160","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.rcl.2017.04.002","volume":"55","author":"E Llopis","year":"2017","unstructured":"Llopis E, Kroon HM, Acosta J, Bloem JL. Conventional radiology in rheumatoid arthritis. Radiol Clin North Am. 2017;55:917\u201341. https:\/\/doi.org\/10.1016\/j.rcl.2017.04.002.","journal-title":"Radiol Clin North Am"},{"key":"3804_CR161","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11926-016-0620-x","volume":"18","author":"Z Stavre","year":"2016","unstructured":"Stavre Z, Upchurch K, Kay J, Gravallese EM. Differential effects of inflammation on Bone and response to biologics in rheumatoid arthritis and Spondyloarthritis. Curr Rheumatol Rep. 2016;18:72. https:\/\/doi.org\/10.1007\/s11926-016-0620-x.","journal-title":"Curr Rheumatol Rep"},{"key":"3804_CR162","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1136\/ard.2005.039826","volume":"65","author":"F Siannis","year":"2006","unstructured":"Siannis F, Farewell VT, Cook RJ, Schentag CT, Gladman DDD. Clinical and radiological damage in psoriatic arthritis. Ann Rheum Dis. 2006;65:478\u201381. https:\/\/doi.org\/10.1136\/ard.2005.039826.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR163","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/ard.2010.132423","volume":"70","author":"S Finzel","year":"2011","unstructured":"Finzel S, Englbrecht M, Engelke K, Stach C, Schett G. A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis. Ann Rheum Dis. 2011;70:122\u20137. https:\/\/doi.org\/10.1136\/ard.2010.132423.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR164","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1172\/JCI200316069.Introduction","volume":"111","author":"C Ritchlin","year":"2003","unstructured":"Ritchlin C, Haas-Smith S. Mechanisms of TNF\u03b1\u2013and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Densitom. 2003;111:821\u201331. https:\/\/doi.org\/10.1172\/JCI200316069.Introduction.","journal-title":"J Clin Densitom"},{"key":"3804_CR165","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1111\/ijd.13159","volume":"55","author":"TE Amin","year":"2016","unstructured":"Amin TE, ElFar NN, Ghaly NR, Hekal MM, Hassan AM, Elsaadany HM. Serum level of receptor activator of nuclear factor kappa-B ligand in patients with psoriasis. Int J Dermatol. 2016;55:e227\u201333. https:\/\/doi.org\/10.1111\/ijd.13159.","journal-title":"Int J Dermatol"},{"key":"3804_CR166","first-page":"105","volume":"25","author":"G Partsch","year":"1998","unstructured":"Partsch G, Wagner E, Leeb BF, Dunky A, Steiner G, Smolen JS. Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid. J Rheumatol. 1998;25:105\u201310 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9458212.","journal-title":"J Rheumatol"},{"key":"3804_CR167","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/ard.2007.076091","volume":"67","author":"AP Anandarajah","year":"2008","unstructured":"Anandarajah AP, Schwarz EM, Totterman S, Monu J, Feng CY, Shao T, et al. The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis. Ann Rheum Dis. 2008;67:296\u2013301. https:\/\/doi.org\/10.1136\/ard.2007.076091.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR168","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4172\/2167-7921.1000158","volume":"04","author":"MS Chimenti","year":"2015","unstructured":"Chimenti MS, Maria Morello PC. A prospective study on inflammatory cytokines and Bone metabolism mediators in patients affected by rheumatoid and psoriatic arthritis treated with Adalimumab. J Arthritis. 2015;04:4\u201311. https:\/\/doi.org\/10.4172\/2167-7921.1000158.","journal-title":"J Arthritis"},{"key":"3804_CR169","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1136\/annrheumdis-2012-201580","volume":"72","author":"S Finzel","year":"2013","unstructured":"Finzel S, Kraus S, Schmidt S, Hueber A, Rech J, Engelke K, et al. Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors. Ann Rheum Dis. 2013;72:1176\u201381. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201580.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4317","volume":"15","author":"H Benham","year":"2013","unstructured":"Benham H, Norris P, Goodall J, Wechalekar MD, FitzGerald O, Szentpetery A, et al. Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Res Ther. 2013;15:1. https:\/\/doi.org\/10.1186\/ar4317.","journal-title":"Arthritis Res Ther"},{"key":"3804_CR171","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1172\/JCI5703","volume":"103","author":"S Kotake","year":"1999","unstructured":"Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999;103:1345\u201352. https:\/\/doi.org\/10.1172\/JCI5703.","journal-title":"J Clin Invest"},{"key":"3804_CR172","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/jcb.22326","volume":"108","author":"T Yago","year":"2009","unstructured":"Yago T, Nanke Y, Ichikawa N, Kobashigawa T, Mogi M, Kamatani N, et al. IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17. J Cell Biochem. 2009;108:947\u201355. https:\/\/doi.org\/10.1002\/jcb.22326.","journal-title":"J Cell Biochem"},{"key":"3804_CR173","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/annrheumdis-2013-204782","volume":"74","author":"IE Adamopoulos","year":"2015","unstructured":"Adamopoulos IE, Suzuki E, Chao C-C, Gorman D, Adda S, Maverakis E, et al. IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis. Ann Rheum Dis. 2015;74:1284\u201392. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204782.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR174","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/art.39685","volume":"68","author":"D van der Heijde","year":"2016","unstructured":"van der Heijde D, Landew\u00e9 RB, Mease PJ, McInnes IB, Conaghan PG, Pricop L, et al. Brief report: Secukinumab provides significant and sustained inhibition of joint structural damage in a phase III study of active psoriatic arthritis. Arthritis Rheumatol. 2016;68:1914\u201321. https:\/\/doi.org\/10.1002\/art.39685.","journal-title":"Arthritis Rheumatol"},{"key":"3804_CR175","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaikh B, Turner SP, Chao C-C, Sathe M, Grein J, et al. IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4-CD8- entheseal resident T cells. Nat Med. 2012;18:1069\u201376. https:\/\/doi.org\/10.1038\/nm.2817.","journal-title":"Nat Med"},{"key":"3804_CR176","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1136\/annrheumdis-2013-204741","volume":"73","author":"A Kavanaugh","year":"2014","unstructured":"Kavanaugh A, Ritchlin C, Rahman P, Puig L, Gottlieb AB, Li S, et al. Ustekinumab, an anti-IL-12\/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-c. Ann Rheum Dis. 2014;73:1000\u20136. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204741.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR177","doi-asserted-by":"crossref","unstructured":"R. C, Deodhar A, Helliwell P, Boencke W, Hsia E, Kollmeier A, et al. Guselkumab, an anti-interleukin-23p19 monoclonal antibody, in patients with active psoriatic arthritis who were biologic-Na\u00efve or prior TNF\u03b1 inhibitor-treated: week 24 results of a phase 3, randomized, double-blind, placebo-controlled study. abstr, Arthritis Rheumatol. 2019;71 https:\/\/acrabstracts.org\/abstract\/guselkumab-an-anti-interleukin-23p19-monoclonal-antibody-in-patients-with-active-psoriatic-arthritis-who-were-biologic-naive-or-prior-tnf\u03b1-inhibitor-treated-week-24-results-of-a-phase-3-rando\/. Accessed 20 Jan 2020.","DOI":"10.1093\/rheumatology\/keaa111.255"},{"key":"3804_CR178","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/ard.2004.034264","volume":"64","author":"D McGonagle","year":"2005","unstructured":"McGonagle D. Imaging the joint and enthesis: insights into pathogenesis of psoriatic arthritis. Ann Rheum Dis. 2005;64:58\u201360. https:\/\/doi.org\/10.1136\/ard.2004.034264.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR179","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s10067-017-3734-2","volume":"36","author":"A Fassio","year":"2017","unstructured":"Fassio A, Idolazzi L, Viapiana O, Benini C, Vantaggiato E, Bertoldo F, et al. In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls. Clin Rheumatol. 2017;36:2377\u201381. https:\/\/doi.org\/10.1007\/s10067-017-3734-2.","journal-title":"Clin Rheumatol"},{"key":"3804_CR180","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/annrheumdis-2011-200216","volume":"71","author":"GR Heiland","year":"2012","unstructured":"Heiland GR, Appel H, Poddubnyy D, Zwerina J, Hueber A, Haibel H, et al. High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis. 2012;71:572\u20134. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200216.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR181","doi-asserted-by":"publisher","first-page":"R164","DOI":"10.1186\/ar3123","volume":"12","author":"N Dalbeth","year":"2010","unstructured":"Dalbeth N, Pool B, Smith T, Callon KE, Lobo M, Taylor WJ, et al. Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. Arthritis Res Ther. 2010;12:R164. https:\/\/doi.org\/10.1186\/ar3123.","journal-title":"Arthritis Res Ther"},{"key":"3804_CR182","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3899\/jrheum.140223","volume":"42","author":"DR Jadon","year":"2015","unstructured":"Jadon DR, Nightingale AL, McHugh NJ, Lindsay MA, Korendowych E, Sengupta R. Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy. J Rheumatol. 2015;42:21\u201330. https:\/\/doi.org\/10.3899\/jrheum.140223.","journal-title":"J Rheumatol"},{"key":"3804_CR183","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/ard.2003.013599","volume":"63","author":"RJU Lories","year":"2004","unstructured":"Lories RJU, Matthys P, De Vlam K, Derese I, Luyten FP. Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA\/1 mice: a model of psoriatic arthritis. Ann Rheum Dis. 2004;63:595\u20138. https:\/\/doi.org\/10.1136\/ard.2003.013599.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR184","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1172\/JCI23738","volume":"115","author":"RJU Lories","year":"2005","unstructured":"Lories RJU, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest. 2005;115:1571\u20139. https:\/\/doi.org\/10.1172\/JCI23738.","journal-title":"J Clin Invest"},{"key":"3804_CR185","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10067-007-0725-8","volume":"27","author":"P Borman","year":"2008","unstructured":"Borman P, Babao\u01e7lu S, Gur G, Bingol S, Bodur H. Bone mineral density and bone turnover in patients with psoriatic arthritis. Clin Rheumatol. 2008;27:443\u20137. https:\/\/doi.org\/10.1007\/s10067-007-0725-8.","journal-title":"Clin Rheumatol"},{"key":"3804_CR186","unstructured":"Gudman NS, Christensen AF, Sorensen GL, Bay-Jensen AC, Siebuhr AS, Karsdal MA, et al. Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacity. Clin.Exp.Rheumatol. 2017;35."},{"key":"3804_CR187","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/ard.48.8.654","volume":"48","author":"P Pietschmann","year":"1989","unstructured":"Pietschmann P, Machold KP, Wolosczuk W, Smolen JS. Serum osteocalcin concentrations in patients with rheumatoid arthritis. Ann Rheum Dis. 1989;48:654\u20137. https:\/\/doi.org\/10.1136\/ard.48.8.654.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR188","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s002960000046","volume":"19","author":"H Franck","year":"2000","unstructured":"Franck H, Ittel T. Serum osteocalcin levels in patients with psoriatic arthritis: an extended report. Rheumatol Int. 2000;19:161\u20134. https:\/\/doi.org\/10.1007\/s002960000046.","journal-title":"Rheumatol Int"},{"key":"3804_CR189","doi-asserted-by":"publisher","first-page":"S273","DOI":"10.1016\/j.bone.2009.03.481","volume":"44","author":"MA Morrin","year":"2009","unstructured":"Morrin MA, Fitzgerald O, McKenna MJ, Brady JJ, Murray BF. The clinical utility of measuring C-terminal telopeptide fragments of type II collagen (CTX-II) in patients with rheumatoid and psoriatic arthritis following anti-TNF-alpha therapy. Bone. 2009;44:S273\u20134. https:\/\/doi.org\/10.1016\/j.bone.2009.03.481.","journal-title":"Bone."},{"key":"3804_CR190","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00296-015-3397-8","volume":"36","author":"HL Munk","year":"2016","unstructured":"Munk HL, Gudmann NS, Christensen AF, Ejstrup L, Sorensen GL, Loft AG, et al. Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27. Rheumatol Int. 2016;36:541\u20139. https:\/\/doi.org\/10.1007\/s00296-015-3397-8.","journal-title":"Rheumatol Int"},{"key":"3804_CR191","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/rheumatology\/keq105","volume":"49","author":"V Chandran","year":"2010","unstructured":"Chandran V, Cook RJ, Edwin J, Shen H, Pellett FJ, Shanmugarajah S, et al. Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology. 2010;49:1399\u2013405. https:\/\/doi.org\/10.1093\/rheumatology\/keq105.","journal-title":"Rheumatology."},{"key":"3804_CR192","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00296-015-3397-8","volume":"36","author":"HL Munk","year":"2016","unstructured":"Munk HL, Gudmann NS, Christensen AF, Ejstrup L, Sorensen GL, Loft AG, et al. Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27. Rheumatol Int. 2016;36:541\u20139. https:\/\/doi.org\/10.1007\/s00296-015-3397-8.","journal-title":"Rheumatol Int"},{"key":"3804_CR193","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13075-016-1040-z","volume":"18","author":"NS Gudmann","year":"2016","unstructured":"Gudmann NS, Munk HL, Christensen AF, Ejstrup L, S\u00f8rensen GL, Loft AG, et al. Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis. Arthritis Res Ther. 2016;18:141. https:\/\/doi.org\/10.1186\/s13075-016-1040-z.","journal-title":"Arthritis Res Ther"},{"key":"3804_CR194","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1136\/ard.60.1.27","volume":"60","author":"B M\u00e5nsson","year":"2001","unstructured":"M\u00e5nsson B, G\u00fclfe A, Geborek P, Heineg\u00e5rd D, Saxne T. Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis. Ann Rheum Dis. 2001;60:27\u201331. https:\/\/doi.org\/10.1136\/ard.60.1.27.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR195","first-page":"1087","volume":"26","author":"M Skoumal","year":"2008","unstructured":"Skoumal M, Haberhauer G, Fink A, Steiner A, Klingler A, Varga F, et al. Increased serum levels of cartilage oligomeric matrix protein in patients with psoriasis vulgaris: a marker for unknown peripheral joint involvement? Clin Exp Rheumatol. 2008;26:1087\u201390.","journal-title":"Clin Exp Rheumatol"},{"key":"3804_CR196","doi-asserted-by":"publisher","unstructured":"Bartosi\u0144ska J, Michalak-Stoma A, Juszkiewicz-Borowiec M, Kowal M, Chodorowska G. The assessment of selected Bone and cartilage biomarkers in psoriatic patients from Poland. Mediators Inflamm. 2015;2015. https:\/\/doi.org\/10.1155\/2015\/194535.","DOI":"10.1155\/2015\/194535"},{"key":"3804_CR197","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s11926-010-0107-0","volume":"12","author":"V Chandran","year":"2010","unstructured":"Chandran V, Gladman DD. Update on biomarkers in psoriatic arthritis. Curr Rheumatol Rep. 2010;12:288\u201394. https:\/\/doi.org\/10.1007\/s11926-010-0107-0.","journal-title":"Curr Rheumatol Rep"},{"key":"3804_CR198","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13075-017-1417-7","volume":"19","author":"DR Jadon","year":"2017","unstructured":"Jadon DR, Sengupta R, Nightingale A, Lu H, Dunphy J, Green A, et al. Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study. Arthritis Res Ther. 2017;19:210. https:\/\/doi.org\/10.1186\/s13075-017-1417-7.","journal-title":"Arthritis Res Ther"},{"key":"3804_CR199","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3899\/jrheum.121162","volume":"40","author":"V Chandran","year":"2013","unstructured":"Chandran V, Shen H, Pollock RA, Pellett FJ, Carty A, Cook RJ, et al. Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis. J Rheumatol. 2013;40:866\u201371. https:\/\/doi.org\/10.3899\/jrheum.121162.","journal-title":"J Rheumatol"},{"key":"3804_CR200","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/annrheumdis-2012-201697","volume":"72","author":"CL Wagner","year":"2013","unstructured":"Wagner CL, Visvanathan S, Elashoff M, Mcinnes IB, Mease PJ, Krueger GG, et al. Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab. Ann Rheum Dis. 2013;72:83. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201697.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR201","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0012556","volume":"5","author":"AWR van Kuijk","year":"2010","unstructured":"van Kuijk AWR, Degroot J, Koeman RC, Sakkee N, Baeten DL, Gerlag DM, et al. Soluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placebo. PLoS One. 2010;5:1\u20135. https:\/\/doi.org\/10.1371\/journal.pone.0012556.","journal-title":"PLoS One"},{"key":"3804_CR202","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/jdv.13269","volume":"30","author":"D Wilsmann-Theis","year":"2016","unstructured":"Wilsmann-Theis D, Wagenpfeil J, Holzinger D, Roth J, Koch S, Schnautz S, et al. Among the S100 proteins, S100A12 is the most significant marker for psoriasis disease activity. J Eur Acad Dermatol Venereol. 2016;30:1165\u201370. https:\/\/doi.org\/10.1111\/jdv.13269.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3804_CR203","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2133.2006.07198.x","volume":"155","author":"S Benoit","year":"2006","unstructured":"Benoit S, Toksoy A, Ahlmann M, Schmidt M, Sunderk\u00f6tter C, Foell D, et al. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. Br J Dermatol. 2006;155:62\u20136. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07198.x.","journal-title":"Br J Dermatol"},{"key":"3804_CR204","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1468-3083.2011.04053.x","volume":"26","author":"I Flisiak","year":"2012","unstructured":"Flisiak I, Zaniewski P, Rogalska-Taranta M, Chodynicka B. Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations. J Eur Acad Dermatol Venereol. 2012;26:302\u20137. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04053.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3804_CR205","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/jcla.21717","volume":"28","author":"A-RMA Meki","year":"2014","unstructured":"Meki A-RMA, Al-Shobaili H. Serum vascular endothelial growth factor, transforming growth factor \u03b21, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity. J Clin Lab Anal. 2014;28:496\u2013501. https:\/\/doi.org\/10.1002\/jcla.21717.","journal-title":"J Clin Lab Anal"},{"key":"3804_CR206","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1155\/MI.2005.273","volume":"2005","author":"O Arican","year":"2005","unstructured":"Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. 2005;2005:273\u20139. https:\/\/doi.org\/10.1155\/MI.2005.273.","journal-title":"Mediators Inflamm"},{"key":"3804_CR207","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1365-2133.2004.05984.x","volume":"150","author":"P Rocha-Pereira","year":"2004","unstructured":"Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. The inflammatory response in mild and in severe psoriasis. Br J Dermatol. 2004;150:917\u201328. https:\/\/doi.org\/10.1111\/j.1365-2133.2004.05984.x.","journal-title":"Br J Dermatol"},{"key":"3804_CR208","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11914-011-0058-z","volume":"9","author":"S Carter","year":"2011","unstructured":"Carter S, Lories RJ. Osteoporosis: a paradox in Ankylosing spondylitis. Curr Osteoporos Rep. 2011;9:112\u20135. https:\/\/doi.org\/10.1007\/s11914-011-0058-z.","journal-title":"Curr Osteoporos Rep"},{"key":"3804_CR209","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/BOR.0b013e328133f57b","volume":"19","author":"E Toussirot","year":"2007","unstructured":"Toussirot E, Wendling D. Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis. Curr Opin Rheumatol. 2007;19:340\u20135. https:\/\/doi.org\/10.1097\/BOR.0b013e328133f57b.","journal-title":"Curr Opin Rheumatol"},{"key":"3804_CR210","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/2040622317702363","volume":"8","author":"G Sambataro","year":"2017","unstructured":"Sambataro G, Sambataro D, Polosa R. Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis. Ther Adv Chronic Dis. 2017;8:97\u20139. https:\/\/doi.org\/10.1177\/2040622317702363.","journal-title":"Ther Adv Chronic Dis"},{"key":"3804_CR211","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/rheumatology\/ket321","volume":"53","author":"O Viapiana","year":"2014","unstructured":"Viapiana O, Gatti D, Idolazzi L, Fracassi E, Adami S, Troplini S, et al. Bisphosphonates vs infliximab in ankylosing spondylitis treatment. Rheumatology (Oxford). 2014;53:90\u20134. https:\/\/doi.org\/10.1093\/rheumatology\/ket321.","journal-title":"Rheumatology (Oxford)"},{"key":"3804_CR212","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/art.22758","volume":"56","author":"D McGonagle","year":"2007","unstructured":"McGonagle D, Lories RJU, Tan AL, Benjamin M. The concept of a \u201csynovio-entheseal complex\u201d and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum. 2007;56:2482\u201391. https:\/\/doi.org\/10.1002\/art.22758.","journal-title":"Arthritis Rheum"},{"key":"3804_CR213","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(97)12004-9","volume":"352","author":"D McGonagle","year":"1998","unstructured":"McGonagle D, Gibbon W, Emery P. Classification of inflammatory arthritis by enthesitis. Lancet. 1998;352:1137\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(97)12004-9.","journal-title":"Lancet."},{"key":"3804_CR214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-015-0805-0","volume":"18","author":"HW Tseng","year":"2016","unstructured":"Tseng HW, Pitt ME, Glant TT, McRae AF, Kenna TJ, Brown MA, et al. Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes. Arthritis Res Ther. 2016;18:1\u201312. https:\/\/doi.org\/10.1186\/s13075-015-0805-0.","journal-title":"Arthritis Res Ther"},{"key":"3804_CR215","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/rheumatology\/kex448","volume":"57","author":"STG Bruijnen","year":"2018","unstructured":"Bruijnen STG, Verweij NJF, van Duivenvoorde LM, Bravenboer N, Baeten DLP, van Denderen CJ, et al. Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by18F-fluoride positron emission tomography. Rheumatol (United Kingdom). 2018;57:631\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/kex448.","journal-title":"Rheumatol (United Kingdom)"},{"key":"3804_CR216","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2496","volume":"10","author":"X Baraliakos","year":"2008","unstructured":"Baraliakos X, Listing J, Rudwaleit M, Sieper J, Braun J. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther. 2008;10:1\u20137. https:\/\/doi.org\/10.1186\/ar2496.","journal-title":"Arthritis Res Ther"},{"key":"3804_CR217","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104966","volume":"9","author":"Y Bin Joo","year":"2014","unstructured":"Bin Joo Y, Bang S, Kim T-H, Shim S, Lee S, Bin Joo K, et al. Bone morphogenetic protein 6 polymorphisms are associated with radiographic progression in ankylosing spondylitis. PLoS One. 2014;9:e104966. https:\/\/doi.org\/10.1371\/journal.pone.0104966.","journal-title":"PLoS One"},{"key":"3804_CR218","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3899\/jrheum.100200","volume":"37","author":"H-A Chen","year":"2010","unstructured":"Chen H-A, Chen C-H, Lin Y-J, Chen P-C, Chen W-S, Lu C-L, et al. Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis. J Rheumatol. 2010;37:2126\u201332. https:\/\/doi.org\/10.3899\/jrheum.100200.","journal-title":"J Rheumatol"},{"key":"3804_CR219","doi-asserted-by":"publisher","unstructured":"Yuan TL, Chen J, Tong YL, Zhang Y, Liu YY, Wei JCC, et al. Serum Heme Oxygenase-1 and BMP-7 are potential biomarkers for Bone metabolism in patients with rheumatoid arthritis and Ankylosing spondylitis. Biomed Res Int. 2016;2016. https:\/\/doi.org\/10.1155\/2016\/7870925.","DOI":"10.1155\/2016\/7870925"},{"key":"3804_CR220","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jbspin.2006.11.005","volume":"74","author":"D Wendling","year":"2007","unstructured":"Wendling D, Cedoz J-P, Racadot E, Dumoulin G. Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine. 2007;74:304\u20135. https:\/\/doi.org\/10.1016\/j.jbspin.2006.11.005.","journal-title":"Joint Bone Spine"},{"key":"3804_CR221","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/art.39433","volume":"68","author":"Z Xie","year":"2016","unstructured":"Xie Z, Wang P, Li Y, Deng W, Zhang X, Su H, et al. Imbalance between Bone morphogenetic protein 2 and noggin induces abnormal Osteogenic differentiation of Mesenchymal stem cells in Ankylosing spondylitis. Arthritis Rheumatol. 2016;68:430\u201340. https:\/\/doi.org\/10.1002\/art.39433.","journal-title":"Arthritis Rheumatol"},{"key":"3804_CR222","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1002\/art.11389","volume":"48","author":"RJU Lories","year":"2003","unstructured":"Lories RJU, Derese I, Ceuppens JL, Luyten FP. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum. 2003;48:2807\u201318. https:\/\/doi.org\/10.1002\/art.11389.","journal-title":"Arthritis Rheum"},{"key":"3804_CR223","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/ard.2008.102046","volume":"69","author":"S Uderhardt","year":"2010","unstructured":"Uderhardt S, Diarra D, Katzenbeisser J, David J-P, Zwerina J, Richards W, et al. Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints. Ann Rheum Dis. 2010;69:592\u20137. https:\/\/doi.org\/10.1136\/ard.2008.102046.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR224","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1186\/ar4096","volume":"14","author":"KR Haynes","year":"2012","unstructured":"Haynes KR, Pettit AR, Duan R, Tseng H-W, Glant TT, Brown MA, et al. Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors. Arthritis Res Ther. 2012;14:R253. https:\/\/doi.org\/10.1186\/ar4096.","journal-title":"Arthritis Res Ther"},{"key":"3804_CR225","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/art.27231","volume":"62","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Liossis SNC, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M, et al. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum. 2010;62:150\u20138. https:\/\/doi.org\/10.1002\/art.27231.","journal-title":"Arthritis Rheum"},{"key":"3804_CR226","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5606\/ArchRheumatol.2016.5857","volume":"31","author":"J Huang","year":"2016","unstructured":"Huang J, Song G, Yin Z, Fu Z, Ye Z. Alteration of Bone turnover markers in canonical wingless pathway in patients with Ankylosing spondylitis. Arch Rheumatol. 2016;31:221\u20138. https:\/\/doi.org\/10.5606\/ArchRheumatol.2016.5857.","journal-title":"Arch Rheumatol"},{"key":"3804_CR227","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/art.40468","volume":"70","author":"X Li","year":"2018","unstructured":"Li X, Wang J, Zhan Z, Li S, Zheng Z, Wang T, et al. Inflammation intensity\u2013dependent expression of Osteoinductive Wnt proteins is critical for ectopic new Bone formation in Ankylosing spondylitis. Arthritis Rheumatol. 2018;70:1056\u201370. https:\/\/doi.org\/10.1002\/art.40468.","journal-title":"Arthritis Rheumatol"},{"key":"3804_CR228","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3899\/jrheum.131199","volume":"41","author":"E Klingberg","year":"2014","unstructured":"Klingberg E, Nurkkala M, Carlsten H, Forsblad-D\u2019Elia H. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis. J Rheumatol. 2014;41:1349\u201356. https:\/\/doi.org\/10.3899\/jrheum.131199.","journal-title":"J Rheumatol"},{"key":"3804_CR229","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3349\/ymj.2008.49.2.288","volume":"49","author":"MC Park","year":"2008","unstructured":"Park MC, Chung SJ, Park YB, Lee SK. Bone and cartilage turnover markers, bone mineral density, and radiographic damage in men with ankylosing spondylitis. Yonsei Med J. 2008;49:288\u201394. https:\/\/doi.org\/10.3349\/ymj.2008.49.2.288.","journal-title":"Yonsei Med J"},{"key":"3804_CR230","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3109\/03009742.2016.1152399","volume":"45","author":"J Gamez-Nava","year":"2016","unstructured":"Gamez-Nava J, de la Cerda-Trujillo L, Vazquez-Villegas M, Cons-Molina F, Alcaraz-Lopez M, Zavaleta-Mu\u00f1iz S, et al. Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitis. Scand J Rheumatol. 2016;45:480\u201390. https:\/\/doi.org\/10.3109\/03009742.2016.1152399.","journal-title":"Scand J Rheumatol"},{"key":"3804_CR231","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1136\/ard.54.7.556","volume":"54","author":"W Marhoffer","year":"1995","unstructured":"Marhoffer W, Stracke H, Masoud I, Scheja M, Graef V, Bolten W, et al. Evidence of impaired cartilage\/bone turnover in patients with active ankylosing spondylitis. Ann Rheum Dis. 1995;54:556\u20139. https:\/\/doi.org\/10.1136\/ard.54.7.556.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR232","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s100670050024","volume":"19","author":"N Yilmaz","year":"2000","unstructured":"Yilmaz N, \u00d6zaslan J. Biochemical bone turnover markers in patients with ankylosing. Clin Rheumatol. 2000;19:92\u20138. https:\/\/doi.org\/10.1007\/s100670050024.","journal-title":"Clin Rheumatol"},{"key":"3804_CR233","doi-asserted-by":"publisher","unstructured":"Arends S, Spoorenberg A, Efde M, Bos R, Leijsma MK, Bootsma H, et al. Higher bone turnover is related to spinal radiographic damage and low bone mineral density in ankylosing spondylitis patients with active disease: a cross-sectional analysis. PLoS One. 2014;9. https:\/\/doi.org\/10.1371\/journal.pone.0099685.","DOI":"10.1371\/journal.pone.0099685"},{"key":"3804_CR234","doi-asserted-by":"publisher","first-page":"644 LP","DOI":"10.1136\/annrheumdis-2012-eular.123","volume":"71","author":"R Pullerits","year":"2013","unstructured":"Pullerits R, M\u00f6rck B, Bremell T, Forsblad d\u2019Elia H. AB0123 increase in serum levels of srankl and SRANKL\/OPG but stable CTX-I in patients with infliximab-treated active ankylosing spondylitis. Ann Rheum Dis. 2013;71:644 LP\u2013644. https:\/\/doi.org\/10.1136\/annrheumdis-2012-eular.123.","journal-title":"Ann Rheum Dis"},{"key":"3804_CR235","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/543806","volume":"2015","author":"P Zhang","year":"2015","unstructured":"Zhang P, Li Q, Wei Q, Liao Z, Lin Z, Fang L, et al. Serum vitamin D and pyridinoline cross-linked carboxyterminal telopeptide of type i collagen in patients with ankylosing spondylitis. Biomed Res Int. 2015;2015:1\u20136. https:\/\/doi.org\/10.1155\/2015\/543806.","journal-title":"Biomed Res Int"},{"key":"3804_CR236","first-page":"2030","volume":"35","author":"WP Maksymowych","year":"2008","unstructured":"Maksymowych WP, Rahman P, Shojania K, Olszynski WP, Thomson GTD, Ballal S, et al. Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis. J Rheumatol. 2008;35:2030\u20137.","journal-title":"J Rheumatol"},{"key":"3804_CR237","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1007\/s00296-011-2237-8","volume":"32","author":"AC Bay-Jensen","year":"2012","unstructured":"Bay-Jensen AC, Leeming DJ, Kleyer A, Veidal SS, Schett G, Karsdal MA. Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study. Rheumatol Int. 2012;32:3565\u201372. https:\/\/doi.org\/10.1007\/s00296-011-2237-8.","journal-title":"Rheumatol Int"},{"key":"3804_CR238","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/art.20870","volume":"52","author":"TH Kim","year":"2005","unstructured":"Kim TH, Stone M, Payne U, Zhang X, Ionescu M, Lobanok T, et al. Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response. Arthritis Rheum. 2005;52:885\u201391. https:\/\/doi.org\/10.1002\/art.20870.","journal-title":"Arthritis Rheum"},{"key":"3804_CR239","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1007\/s00296-011-2237-8","volume":"32","author":"AC Bay-Jensen","year":"2012","unstructured":"Bay-Jensen AC, Leeming DJ, Kleyer A, Veidal SS, Schett G, Karsdal MA. Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study. Rheumatol Int. 2012;32:3565\u201372. https:\/\/doi.org\/10.1007\/s00296-011-2237-8.","journal-title":"Rheumatol Int"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03804-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-020-03804-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03804-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T04:31:07Z","timestamp":1606624267000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-020-03804-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,28]]},"references-count":239,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3804"],"URL":"https:\/\/doi.org\/10.1186\/s12891-020-03804-2","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,28]]},"assertion":[{"value":"6 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Conflicts of interest: Christian S. Thudium, Signe Holm Nielsen, Kim Henriksen, Anne-Christine Bay-Jensen and Morten A. Karsdal are full time employees at Nordic Bioscience, a biotech company involved in the development of biochemical markers. Kim Henriksen, Anne-Christine Bay-Jensen and Morten Karsdal holds stocks in Nordic Bioscience.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"789"}}